Conference Proceedings

BluePrint performance in predicting pertuzumab benefit in genomically HER2-positive patients: A biomarker analysis of the APHINITY trial

Ian Krop, Lorenza Mittempergher, Joseph Paulson, Fabrice Andre, Herve Bonnefoi, Sherene Loi, Sibylle Loibl, Richard D Gelber, Carmela Caballero, Debora Fumagalli, Christa Dreezen, Rene Bernards, Laura van't Veer, Martine Piccart

CANCER RESEARCH | AMER ASSOC CANCER RESEARCH | Published : 2021